id: 585, Created by Stan Vick, Scout
Corcept Therapeutics (CORT) $14M Securities Settlement
How it works?
- Company agreed to settle with investors to avoid further litigation
- We prepare documents and claim payout for you
02 Aug 2017Class period Start
31 Jan 2019Class period End
Corcept Therapeutics (CORT) agreed to settle $14 million with investors to end a securities class action lawsuit over concealing that it improperly paid doctors to promote its drug Korlym and inflated its revenue and sales using illicit sales practices through a related party.
Investors who bought $CORT or call options to purchase common stock of Corcept between August 2, 2017, through January 31, 2019, inclusive, may be entitled to a payout.
Failure to Disclose,
Payout per Share
14 March 2019
Lead Plaintiff Deadline
13 May 2019
Ferraro Family Foundation
Levi & Korsinsky, LLP (San Francisco, CA)
Joseph K. Belanoff, Charles Robb, Sean Maduck
Hon. Lucy H. Koh
A.B. Data Ltd
Settlement agreement date
Trades matching type
+$14,000,000Total Settlement Amount